Who invested in Xaira Therapeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Valuation: $2.1B, Mar 2026

Funding summaryUpdated 26 Oct 2026

$1.0Braised across 1 round since 2024, from 1 source

Latest round: Series A, $1.0BApr 2024
Investors: 6

See who backed them

The rounds

Apr 2024
Series A$1.0B
Source recorded

Founders and team

From Xaira Therapeutics's own website: 9 on the team.

Marc Tessier-LavigneChairman & Chief Executive Officer
Bo WangChief AI Scientist
Ci ChuChief Discovery Officer
Debbie LawChief Scientific Officer
Hetu KamichettyChief Technology Officer
Julia TranChief People Officer
Alex GorskyDirector
Carolyn R. BertozziDirector
Kaye FosterDirector

AdvisersAnima AnandkumarDiane MathisJeff JonkerRegina BarzilayRichard SchellerRod MacKinnonSarah TeichmannScientific Advisor

Everyone who backed them

Sequoia CapitalVC firm1round

Lightspeed Venture PartnersVC firm1round

Menlo VenturesVC firm1round

Lux CapitalVC firm1round

ARCH Venture PartnersVC firm1round

Foresite CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Xaira Therapeutics

Who invested in Xaira Therapeutics?

Xaira Therapeutics's investors include Sequoia Capital, Lightspeed Venture Partners, Menlo Ventures, Lux Capital and ARCH Venture Partners, and 1 more on record.